MyOme and SickKids Collaborate to Clinically Validate DNA Methylation Signatures Using Long-Read Sequencing
The Quick Take
MyOme Licenses SickKids-Developed DNA Methylation Signatures to Strengthen Long-Read Rare Disease Testing. MENLO PARK, Calif., Nov. 4, 2026 /PRNewswire/ -- MyOme, a CLIA-certified, CAP-accredited clinical whole-genome analysis company, today announced a licensing and research agreement...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Blue Chips Surge Past 2.8% as VIX Drops Below 18 While Oil Sinks Nearly 8%
VANCOUVER, BC, Nov. 4, 2026 /PRNewswire/ -- Stock Preachers News Commentary - Wall Street roared higher this week, with the Dow jumping 2.87% in a single…
Local
In HelloNation, Roofing Expert Brian Dyck Explains How Spray Foam Roofing Works for Commercial Properties
Spray Foam Roofing Offers a Seamless, Insulating Alternative to Conventional Systems for Flat and Low-Slope Commercial Buildings. MERCED, Calif., Nov. 4, 2026…
Business
Saul Centers set to report earnings amid 52-week low
Business